Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Hamostaseologie
|
October 28, 2024
Be Curious. Try New Things
Johannes Thaler
Blood
|
November 8, 2019
How I treat patients with hereditary antithrombin deficiency
Ingrid Pabinger, Johannes Thaler
Frontiers in Cardiovascular Medicine
|
December 15, 2015
Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the Art
Johannes Thaler, Ingrid Pabinger, Cihan Ay
Thrombosis and Haemostasis
|
July 28, 2012
Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials
Johannes Thaler, Cihan Ay, Ingrid Pabinger
Hamostaseologie
|
October 23, 2024
Investigations on the Hemostatic Potential of Physiological Body Fluids
Johannes Thaler, Carla Tripisciano, Rienk Nieuwland
Blood
|
August 3, 2013
Biomarkers for prediction of venous thromboembolism in cancer
Ingrid Pabinger, Johannes Thaler, Cihan Ay
Research and Practice in Thrombosis and Haemostasis
|
November 11, 2021
The path of uncovering a prothrombotic thrombocytopenic syndrome after viral vector-based COVID-19 vaccination: Where there is much light, the shadow is deep
Johannes Thaler, Cihan Ay, Paul Knoebl
Pharmaceuticals (Basel, Switzerland)
|
October 23, 2021
Extracellular Vesicles in Human Milk
Yong Hu, Johannes Thaler, Rienk Nieuwland
Cancers
|
August 26, 2023
Plasma Clot Properties in Patients with Pancreatic Cancer
Johannes Thaler, Gerald Prager, Ingrid Pabinger, et al.
Thrombosis Research
|
January 21, 2014
Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia
Johannes Thaler, Ingrid Pabinger, Wolfgang R Sperr, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Hamostaseologie
|
October 28, 2024
Be Curious. Try New Things
Johannes Thaler
Blood
|
November 8, 2019
How I treat patients with hereditary antithrombin deficiency
Ingrid Pabinger, Johannes Thaler
Frontiers in Cardiovascular Medicine
|
December 15, 2015
Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the Art
Johannes Thaler, Ingrid Pabinger, Cihan Ay
Thrombosis and Haemostasis
|
July 28, 2012
Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials
Johannes Thaler, Cihan Ay, Ingrid Pabinger
Hamostaseologie
|
October 23, 2024
Investigations on the Hemostatic Potential of Physiological Body Fluids
Johannes Thaler, Carla Tripisciano, Rienk Nieuwland
Blood
|
August 3, 2013
Biomarkers for prediction of venous thromboembolism in cancer
Ingrid Pabinger, Johannes Thaler, Cihan Ay
Research and Practice in Thrombosis and Haemostasis
|
November 11, 2021
The path of uncovering a prothrombotic thrombocytopenic syndrome after viral vector-based COVID-19 vaccination: Where there is much light, the shadow is deep
Johannes Thaler, Cihan Ay, Paul Knoebl
Pharmaceuticals (Basel, Switzerland)
|
October 23, 2021
Extracellular Vesicles in Human Milk
Yong Hu, Johannes Thaler, Rienk Nieuwland
Cancers
|
August 26, 2023
Plasma Clot Properties in Patients with Pancreatic Cancer
Johannes Thaler, Gerald Prager, Ingrid Pabinger, et al.
Thrombosis Research
|
January 21, 2014
Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia
Johannes Thaler, Ingrid Pabinger, Wolfgang R Sperr, et al.
Page
of 6